Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 43 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Veliparib in addition to carboplatin and paclitaxel for epithelial ovarian, fallopian tube, or primary peritoneal cancer	Carboplatin (Paraplatin) , Paclitaxel (Taxol; paclitaxel albumin) , Veliparib (ABT-888; NSC 737664)	Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer	Female Reproductive Cancer	2018	View \| Download
Tisotumab vedotin for recurrent or metastatic cervical cancer	Tisotumab vedotin (HuMax-TF-ADC)	Cervical cancer	Female Reproductive Cancer	2019	View \| Download
Selinexor for advanced or recurrent endometrial cancer - maintenance therapy	Selinexor (KPT-330; Xpovio)	Endometrial cancer	Female Reproductive Cancer	2020	View \| Download
Rucaparib maintenance therapy for ovarian, fallopian tube or primary peritoneal cancer after frontline platinum-based chemotherapy	Rucaparib (Rubraca; PF-1367338)	Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer	Female Reproductive Cancer	2022	View \| Download
Rucaparib (Rubraca) for platinum-sensitive, high-grade serous or endometrioid epithelial ovarian cancer, primary peritoneal or fallopian tube cancer	Rucaparib (Rubraca; PF-1367338)	Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer	Female Reproductive Cancer	2018	View \| Download
Phelinun for reduced intensity conditioning treatment prior to allogeneic haematopoietic stem cell transplantation	Melphalan hydrochloride (Cydex; CDX-353; Phelinun)	Acute myeloid leukaemia (AML) , Hodgkin lymphoma , Multiple myeloma (MM) , Neuroblastoma , Non-Hodgkin lymphoma (NHL) , Ovarian cancer	Female Reproductive Cancer , Haematological Cancer and Lymphomas , Neurological Cancer	2021	View \| Download
Pembrolizumab with chemotherapy for treating advanced or recurrent endometrial cancer	Chemotherapy , Pembrolizumab (Keytruda; MK-3475)	Endometrial cancer	Female Reproductive Cancer	2023	View \| Download
Pembrolizumab with chemotherapy for platinum-resistant recurrent ovarian cancer after 1 or 2 therapies	Chemotherapy , Pembrolizumab (Keytruda; MK-3475)	Ovarian cancer	Female Reproductive Cancer	2023	View \| Download
Pembrolizumab with chemoradiotherapy for treating high-risk locally advanced cervical cancer	Chemoradiotherapy , Pembrolizumab (Keytruda; MK-3475)	Cervical cancer	Female Reproductive Cancer	2022	View \| Download
Pembrolizumab inaddition to chemotherapy for persistent, recurrent or metastatic cervical cancer – first line	Pembrolizumab (Keytruda; MK-3475)	Cervical cancer	Female Reproductive Cancer	2020	View \| Download